Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-04

Clinical Trial Update: A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports pharmacokinetic data for mezigdomide in adults with renal impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mezigdomide (mezigdomide)

Snippet

Sponsor: Celgene | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED